局部5-氟尿嘧啶与干扰素α-2b作为眼表鳞状上皮肿瘤一线治疗的比较
单变量分析中5FU缓解频率高于IFN(96.3% vs 81.3%,P=.01),但多变量分析中治疗方式不再是显著预测因子;两组复发率(11.5% vs 5.1%,P=.46)和复发时间曲线相似,5FU的眼睑水肿和流泪更显著。
要点
- 5FU与IFN作为OSSN一线治疗均有高缓解率和低复发率。
- 单变量分析5FU缓解频率高于IFN,但多变量分析治疗方式非显著预测因子。
- 5FU的眼睑水肿和流泪副作用更显著,复发率两组无显著差异。
核心结论
- 5FU和IFN滴眼液作为OSSN一线治疗均有效,肿瘤缓解频率高且复发率低。
- 单变量分析中5FU缓解频率高于IFN,但多变量分析中治疗方式不是缓解的显著预测因子。
研究设计与样本
- 主要结局为临床缓解频率和OSSN复发时间,次要结局为每种治疗的副作用频率。
主要发现
- 患者平均年龄68岁,接受5FU治疗的西班牙裔更多。
- 单变量分析OSSN缓解频率5FU组96.3%(n=52)高于IFN组81.3%(n=39),P=.01;多变量分析治疗方式不是显著预测因子。
- 缓解患者中缓解时间两组相似:5FU平均6.6个月(SD 4.5)vs IFN平均5.5个月(SD 2.9),P=.17。
- 5FU组52眼中11.5%(n=6)复发,IFN组39眼中5.1%(n=2)复发,P=.46;Kaplan-Meier复发曲线相似(log-rank=0.16)。
- 1年复发率5FU为11.4%,IFN为4.5%;眼睑水肿(P=.04)和流泪(P=.02)在5FU组更显著。
关键数值与推荐
- OSSN缓解频率:5FU 96.3%(n=52)vs IFN 81.3%(n=39),P=.01(单变量分析)。
- 缓解时间:5FU平均6.6个月(SD 4.5)vs IFN平均5.5个月(SD 2.9),P=.17。
- 复发率:5FU 11.5%(n=6)vs IFN 5.1%(n=2),P=.46;1年复发率5FU 11.4%,IFN 4.5%。
- 副作用:眼睑水肿P=.04,流泪P=.02,均为5FU更显著。
临床怎么用
- 5FU和IFN滴眼液均可作为OSSN的一线治疗选择,两者缓解率高且复发率低。
- 选择5FU时需注意眼睑水肿和流泪副作用更显著,应权衡利弊。
局限性
- 回顾性研究设计可能存在选择偏倚。
- 两组种族分布不均衡(接受5FU治疗的西班牙裔更多)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To compare the efficacy of topical 5-fluorouracil 1% (5FU) and interferon alfa-2b 1 MIU/mL (IFN) eye drops as primary treatment modalities for ocular surface squamous neoplasia (OSSN). DESIGN: Retrospective, comparative, interventional case series. METHODS: Fifty-four patients who received 5FU and 48 patients who received IFN as primary therapy for OSSN were included. Primary outcome measures were the frequency of clinical resolution and time to OSSN recurrence by treatment modality. Secondary outcome was the frequency of side effects with each therapy. RESULTS: The mean age of patients was 68 years. More Hispanics were treated with 5FU. In a univariable analysis, frequency of OSSN resolution was higher with 5FU (96.3%, n = 52) than with IFN (81.3%, n = 39), P = .01. In a multivariable analysis, treatment modality did not remain a significant predictor of resolution. In patients whose OSSN resolved, time to resolution was similar with both agents, (5FU mean 6.6 months, standard deviation (SD) 4.5 vs IFN mean 5.5 months, SD 2.9, P = .17). Of the 52 eyes whose OSSN resolved with 5FU, 11.5% of lesions (n = 6) recurred, whereas of the 39 eyes whose OSSN resolved with IFN, 5.1% of lesions (n = 2) recurred, P = .46. Kaplan-Meier survival curves of OSSN recurrence were similar between groups (log-rank = 0.16). One-year recurrence rates were 11.4% with 5FU and 4.5% with IFN. Eyelid edema (P = .04) and tearing (P = .02) were more significant with 5FU. CONCLUSIONS: This is the first direct comparison study between 5FU and IFN eye drops as primary treatment modalities for OSSN. Both modalities resulted in a high frequency of tumor resolution and low recurrence rates and are effective treatment options for OSSN.
引用
- Venkateswaran N, Mercado C, Galor A, et al. Comparison of Topical 5-Fluorouracil and Interferon Alfa-2b as Primary Treatment Modalities for Ocular Surface Squamous Neoplasia. Am J Ophthalmol. 2018. PMID: 30471241. doi:10.1016/j.ajo.2018.11.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。